FDA

The pharmaceutical company pulled three lots of epinephrine injections after discovering particulate matter including glass and nylon that could cause blood clots or organ damage.

Federal health officials traced the parasitic infection across 20 states to iceberg lettuce from Taylor Farms de Mexico, with illnesses continuing to climb since the July recall.

Daraxonrasib cleared 6.5 months early with Phase 3 data showing median 13.2-month survival versus 6.7 months on chemotherapy in second-line metastatic pancreatic cancer.

Dr. Heidi Overton, deputy director of domestic policy, has shaped the administration's vaccine schedule overhaul and drug pricing strategy from inside the White House.

Two deaths confirmed Aug. 3 as FDA human food inspection vacancies approach 20 percent and CDC's parasite-tracking team falls from 11 scientists to three.

The Massachusetts senator's letter to RFK Jr. ties Taylor Farms' seven-figure donations to regulatory rollbacks she says raised the risk of the largest cyclosporiasis outbreak on record.

Health and Human Services Secretary Robert F. Kennedy Jr. faces scrutiny over federal budget cuts as a cyclospora outbreak sickens thousands across the country

The Pharmacy Compounding Advisory Committee voted 9-4 to add 20 peptide substances to the permitted compounding list, overriding internal FDA safety warnings.

Lilly's triple-receptor weight-loss drug retatrutide heads to FDA with a 24 percent efficacy edge over rivals and a $1,200 price target from JPMorgan.

The nation's highest court faces a critical decision on mail-order abortion pills, potentially reshaping the pharmaceutical market and igniting a new wave of political spending.